The effects on tracheal morphology were particularly notable, suggesting that the respiratory complications associated with the tracheal pathology in MPS patients may benefit from the positive effects of combined ERT/anti-TNF-alpha therapy [23], [32]. The gene discussed is TNF; the disease is mucopolysaccharidosis.